Cas:1533519-99-1 1533519-99-1 manufacturer & supplier

Chemical Name:1533519-99-1

CAS.NO:1533519-99-1

Synonyms:4-[[5-[(Carboxymethyl)thio]-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]amino]-4-oxobutanoic acid

Molecular Formula:C₂₁H₂₀N₄O₅S

Molecular Weight:440.47

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:1.56±0.1 g/cm3 (20 ºC 760 Torr)

Index of Refraction:

PSA:

Exact Mass:

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-[[5-[(Carboxymethyl)thio]-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]amino]-4-oxobutanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-[[5-[(Carboxymethyl)thio]-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]amino]-4-oxobutanoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-[[5-[(Carboxymethyl)thio]-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]amino]-4-oxobutanoic acid Use and application,4-[[5-[(Carboxymethyl)thio]-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]amino]-4-oxobutanoic acid technical grade,usp/ep/jp grade.

Related News: For one, people who are surrounded by others of similar body size may not perceive their weight to be outside of the norm and therefore not seek out bariatric surgery,” said Sandon. “[And] there are differences in ethnicities and culture between states with the highest rates of obesity compared to states with lower rates. 1533519-99-1 manufacturer For one, people who are surrounded by others of similar body size may not perceive their weight to be outside of the norm and therefore not seek out bariatric surgery,” said Sandon. “[And] there are differences in ethnicities and culture between states with the highest rates of obesity compared to states with lower rates. 1533519-99-1 supplier For one, people who are surrounded by others of similar body size may not perceive their weight to be outside of the norm and therefore not seek out bariatric surgery,” said Sandon. “[And] there are differences in ethnicities and culture between states with the highest rates of obesity compared to states with lower rates. 1533519-99-1 vendor CMO services mainly involve four stages: pre-clinical research, clinical trials, sales of patented drugs after listing, and sales of original drug products after patents expire. Its advantages are: lower cost, guaranteed quality, good capacity flexibility, and favorable process Promotion. 1533519-99-1 factory Johnson & Johnson’s Darzalex has comfortably been the only CD38 multiple myeloma drug on the market for years until Sanofi hit the scene last year with Sarclisa. Now, just as the competition’s slated to intensify, the U.S. company is building its case with new patient survival data.